Ligand Efficiency Indices (LEIs): More than a Simple Efficiency Yardstick

被引:17
作者
Abad-Zapatero, Cele [1 ]
Blasi, Daniel [2 ]
机构
[1] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA
[2] Parc Cient Barcelona PCB, E-08028 Barcelona, Spain
关键词
Ligand efficiency indices; Chemico-biological space; AtlasCBS; LEIs; PDBBIND DATABASE; CHEMICAL SPACE; DRUG;
D O I
10.1002/minf.201000161
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The concept of ligand efficiency and the usage of ligand efficiency values to assess the quality of fragments and compounds is becoming more accepted in the practice of medicinal chemistry. This is particularly true as it refers to the efficiency of ligands per unit size (i.e., binding affinity/ number of non-hydrogen atoms or binding affinity/MW). The use of the Ligand Efficiency Indices (LEIs) as variables for a Cartesian mapping of chemico-biological space, the concept of AtlasCBS, has been presented in a recent publi-cation with some initial drug-discovery applications. In this communication, we present additional applications of the concept in three domains of drug discovery: i) analyze and compare the content of databases: inhibitors vs. drugs; ii) polypharmacology; and iii) applications to Fragment-Based strategies. We suggest that the combined use of LEIs in a Cartesian representation of Chemico-Biological Space (AtlasCBS) could be a useful tool in various aspects of drugdiscovery in the future.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 19 条
[1]   Ligand efficiency indices as guideposts for drug discovery [J].
Abad-Zapatero, C ;
Metz, JT .
DRUG DISCOVERY TODAY, 2005, 10 (07) :464-469
[2]   Ligand efficiency indices for effective drug discovery [J].
Abad-Zapatero, Cele .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (04) :469-488
[3]   Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation [J].
Abad-Zapatero, Cele ;
Perisic, Ognjen ;
Wass, John ;
Bento, A. Patricia ;
Overington, John ;
Al-Lazikani, Bissan ;
Johnson, Michael E. .
DRUG DISCOVERY TODAY, 2010, 15 (19-20) :804-811
[4]   Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin [J].
Andersen, Ole A. ;
Nathubhai, Amit ;
Dixon, Mark J. ;
Eggleston, Ian M. ;
van Aalten, Daan M. F. .
CHEMISTRY & BIOLOGY, 2008, 15 (03) :295-301
[5]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[6]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[7]   Calculation of protein-ligand binding affinities [J].
Gilson, Michael K. ;
Zhou, Huan-Xiang .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2007, 36 :21-42
[8]   A decade of fragment-based drug design: strategic advances and lessons learned [J].
Hajduk, Philip J. ;
Greer, Jonathan .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (03) :211-219
[9]   Ligand efficiency: a useful metric for lead selection [J].
Hopkins, AL ;
Groom, CR ;
Alex, A .
DRUG DISCOVERY TODAY, 2004, 9 (10) :430-431
[10]   Navigating chemical space for biology and medicine [J].
Lipinski C. ;
Hopkins A. .
Nature, 2004, 432 (7019) :855-861